The sponsor is doing this study because they want to learn certain things about the study drug Lenacapavir (LEN), including: • How LEN moves through the body. • How safe and tolerable LEN is when injected into the muscle once yearly.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Lina Rosengren-Hovee
Medicine-Infectious Diseases
Clinical or Medical
Interventional
HIV/AIDS
25-1551
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
